Greenwich LifeSciences Inc (GLSI) USD0.001

Sell:$24.76Buy:$25.13Price increased$1.85 (8.08%)

Prices delayed by at least 15 minutes
Sell:$24.76
Buy:$25.13
Change:Price increased$1.85 (8.08%)
Deal now
Prices delayed by at least 15 minutes
Sell:$24.76
Buy:$25.13
Change:Price increased$1.85 (8.08%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$24.05
Previous close$22.91
Market cap$339.71m
P/E ratio-
Volume92,545
Dividend yield0.00%
EMS-

Company information

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue13.85m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.